Finance

Lists
Q3 2026 earnings • released • EPS beat +1.18% • Revenue beat +0.22%
See results
WTW:NASDAQ
Willis Towers Watson PLC
$325.51
+0.34%
(+1.09) 1D
$325.67
+0.05% (+0.16)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WTW...
Open
$323.00
High
$327.42
Low
$322.46
Mkt. cap
21.91B
Avg. vol.
537.71K
Volume
1.01M
52-wk high
$351.51
52-wk low
$240.61
Beta
0.46
Shares outstanding
92.22M
No. of employees
48K
Open
$323.00
High
$327.42
Low
$322.46
Mkt. cap
21.91B
Avg. vol.
537.71K
Volume
1.01M
52-wk high
$351.51
52-wk low
$240.61
Beta
0.46
Shares outstanding
92.22M
No. of employees
48K
News stories
From web sources and news partners
Profile
Willis Towers Watson plc is a British-American multinational advisory, broking and solutions company. Its operations span commercial insurance brokerage and risk advisory, employee benefits and rewards consulting, retirement and actuarial services, and investment advice for pension funds and institutional investors. The company is legally domiciled in Ireland and has its principal executive offices at the Willis Building in London. In 2024 WTW reported revenue of US$9.93 billion and employed about 48,900 people. Following completion of the Willis Group - Towers Watson merger, the company was added to the S&P 500 index in January 2016. WTW ranks among the largest global insurance brokers by revenue. Wikipedia
About Willis Towers Watson PLC
CEOCarl Hess
Employees48.1K
FoundedJan 4, 2016
HeadquartersLondon, Greater London, United Kingdom
SectorInsurance
Websitewtwco.com
Analyst ratings
Based on 15 analysts giving stock ratings to WTW in the past 3 months
Buy
Buy
9
Hold
6
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for WTW in the last 3 months.
Highest
Current $325.51
$455.00 (+39.78%)
Average
$369.13 (+13.40%)
Lowest
$310.00 (-4.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Meredith
UBS
Buy
Maintained
$395.00
+21.3%
11/02/2026
Elyse Greenspan
Wells Fargo
Hold
Reiterated
$360.00
+10.6%
11/02/2026
Mark Marcon
Robert W. Baird
Buy
Reiterated
$383.00
+17.7%
11/02/2026
Yaron Kinar
Mizuho Securities
Buy
Maintained
$370.00
+13.7%
11/02/2026
David Motemaden
Evercore ISI
Buy
Maintained
$371.00
+14%
10/30/2026
Alex Scott
Barclays
Hold
Maintained
$332.00
+2%
10/30/2026
Paul Newsome
Piper Sandler
Buy
Maintained
$361.00
+10.9%
10/26/2026
Joshua Shanker
Bank of America Securities
Hold
Maintained
$365.00
+12.1%
10/12/2026
Meyer Shields
KBW
Buy
Maintained
$360.00
+10.6%
10/12/2026
Bob Huang
Morgan Stanley
Hold
Maintained
$310.00
-4.8%
10/06/2026
Michael Zaremski
BMO Capital
Buy
Maintained
$365.00
+12.1%
09/09/2026
Andrew Kligerman
TD Cowen
Buy
Reiterated
$455.00
+39.8%
08/20/2026
Ryan Tunis
Cantor Fitzgerald
Hold
Reiterated
$380.00
+16.7%
08/03/2026
Robert Cox CFA
Goldman Sachs
Buy
Maintained
$385.00
+18.3%
08/03/2026
Matthew Heimermann
Citi
Hold
Downgraded
$345.00
+6%
08/04/2026
Mark Hughes
Truist Financial
Buy
Reiterated
$400.00
+22.9%
07/31/2026
Harry Fong
Roth MKM
Buy
Maintained
$370.00
+13.7%
07/31/2026
Adam Klauber
William Blair
Hold
Maintained
-
-
07/30/2026
Gregory Peters
Raymond James
Buy
Maintained
$340.00
+4.5%
05/06/2026
Andrew Andersen
Jefferies
Buy
Maintained
-
-
03/31/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
$3.63 / $3.59
+1.18%beat
Revenue / Est. (USD)
2.46B / 2.45B
+0.22%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
2.94B
2.41B
2.47B
2.46B
Cost of goods sold
1.44B
1.43B
1.54B
1.49B
Cost of revenue
1.44B
1.43B
1.54B
1.49B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.00M
39.00M
41.00M
41.00M
Operating expense
462.00M
489.00M
490.00M
481.00M
Total operating expenses
1.90B
1.92B
2.03B
1.97B
Operating income
1.04B
495.00M
433.00M
491.00M
Other non operating income
-1.00M
-1.00M
-2.00M
-
EBT including unusual items
933.00M
373.00M
288.00M
388.00M
EBT excluding unusual items
952.00M
414.00M
349.00M
394.00M
Income tax expense
197.00M
70.00M
57.00M
79.00M
Effective tax rate
21.11%
18.77%
19.79%
20.36%
Other operating expenses
312.00M
346.00M
339.00M
326.00M
Net income
735.00M
297.00M
229.00M
303.00M
Net profit margin
25.03%
12.31%
9.29%
12.32%
Earnings per share
8.12
3.72
3.35
3.63
Interest and investment income
-
-
-
-
Interest expense
-66.00M
-77.00M
-78.00M
-80.00M
Net interest expenses
-66.00M
-77.00M
-78.00M
-80.00M
Depreciation and amortization charges
59.00M
56.00M
55.00M
55.00M
EBITDA
1.15B
597.00M
540.00M
600.00M
Gain or loss from assets sale
-
-
-
-37.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps